注射式標的治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2376)
◆英語タイトル:Global Injectable Targeted Therapy Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2376
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:109
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、注射式標的治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(モノクローナル抗体、小分子、免疫毒素、その他)、用途別市場規模(病院、在宅医療、専門クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・注射式標的治療の市場動向
・企業の競争状況、市場シェア
・注射式標的治療の種類別市場規模(モノクローナル抗体、小分子、免疫毒素、その他)
・注射式標的治療の用途別市場規模(病院、在宅医療、専門クリニック、その他)
・注射式標的治療の北米市場規模2016-2027(アメリカ、カナダ)
・注射式標的治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・注射式標的治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・注射式標的治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・注射式標的治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Novartis、Sanofi、GSK、Bayer、Amgen、Merck、AbbiVie、AstraZeneca、Teva、Roche、Pfizer)
・結論
【レポートの概要】

It is at the cellular and molecular level, designed for the treatment of well-defined carcinogenic sites, and designing corresponding therapeutic drugs. When drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing tumor cells to die specifically, without Will affect the normal tissue cells around the tumor.

Market Analysis and Insights: Global Injectable Targeted Therapy Market
The global Injectable Targeted Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Injectable Targeted Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Injectable Targeted Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Injectable Targeted Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Injectable Targeted Therapy market.

Global Injectable Targeted Therapy Scope and Market Size
Injectable Targeted Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Targeted Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monoclonal Antibodies
Small-Molecules
Immunotoxins
Others

Segment by Application
Hospitals
Homecare
Specialty Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Sanofi
GSK
Bayer
Amgen
Merck
AbbiVie
AstraZeneca
Teva
Roche
Pfizer

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Targeted Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Small-Molecules
1.2.4 Immunotoxins
1.2.5 Others
1.3 Market by Application
1.3.1 Global Injectable Targeted Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Injectable Targeted Therapy Market Perspective (2016-2027)
2.2 Injectable Targeted Therapy Growth Trends by Regions
2.2.1 Injectable Targeted Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Injectable Targeted Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Injectable Targeted Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Injectable Targeted Therapy Industry Dynamic
2.3.1 Injectable Targeted Therapy Market Trends
2.3.2 Injectable Targeted Therapy Market Drivers
2.3.3 Injectable Targeted Therapy Market Challenges
2.3.4 Injectable Targeted Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Injectable Targeted Therapy Players by Revenue
3.1.1 Global Top Injectable Targeted Therapy Players by Revenue (2016-2021)
3.1.2 Global Injectable Targeted Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Injectable Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Injectable Targeted Therapy Revenue
3.4 Global Injectable Targeted Therapy Market Concentration Ratio
3.4.1 Global Injectable Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Targeted Therapy Revenue in 2020
3.5 Injectable Targeted Therapy Key Players Head office and Area Served
3.6 Key Players Injectable Targeted Therapy Product Solution and Service
3.7 Date of Enter into Injectable Targeted Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Injectable Targeted Therapy Breakdown Data by Type
4.1 Global Injectable Targeted Therapy Historic Market Size by Type (2016-2021)
4.2 Global Injectable Targeted Therapy Forecasted Market Size by Type (2022-2027)

5 Injectable Targeted Therapy Breakdown Data by Application
5.1 Global Injectable Targeted Therapy Historic Market Size by Application (2016-2021)
5.2 Global Injectable Targeted Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Injectable Targeted Therapy Market Size (2016-2027)
6.2 North America Injectable Targeted Therapy Market Size by Type
6.2.1 North America Injectable Targeted Therapy Market Size by Type (2016-2021)
6.2.2 North America Injectable Targeted Therapy Market Size by Type (2022-2027)
6.2.3 North America Injectable Targeted Therapy Market Size by Type (2016-2027)
6.3 North America Injectable Targeted Therapy Market Size by Application
6.3.1 North America Injectable Targeted Therapy Market Size by Application (2016-2021)
6.3.2 North America Injectable Targeted Therapy Market Size by Application (2022-2027)
6.3.3 North America Injectable Targeted Therapy Market Size by Application (2016-2027)
6.4 North America Injectable Targeted Therapy Market Size by Country
6.4.1 North America Injectable Targeted Therapy Market Size by Country (2016-2021)
6.4.2 North America Injectable Targeted Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Injectable Targeted Therapy Market Size (2016-2027)
7.2 Europe Injectable Targeted Therapy Market Size by Type
7.2.1 Europe Injectable Targeted Therapy Market Size by Type (2016-2021)
7.2.2 Europe Injectable Targeted Therapy Market Size by Type (2022-2027)
7.2.3 Europe Injectable Targeted Therapy Market Size by Type (2016-2027)
7.3 Europe Injectable Targeted Therapy Market Size by Application
7.3.1 Europe Injectable Targeted Therapy Market Size by Application (2016-2021)
7.3.2 Europe Injectable Targeted Therapy Market Size by Application (2022-2027)
7.3.3 Europe Injectable Targeted Therapy Market Size by Application (2016-2027)
7.4 Europe Injectable Targeted Therapy Market Size by Country
7.4.1 Europe Injectable Targeted Therapy Market Size by Country (2016-2021)
7.4.2 Europe Injectable Targeted Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Injectable Targeted Therapy Market Size (2016-2027)
8.2 Asia-Pacific Injectable Targeted Therapy Market Size by Type
8.2.1 Asia-Pacific Injectable Targeted Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Injectable Targeted Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Injectable Targeted Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Injectable Targeted Therapy Market Size by Application
8.3.1 Asia-Pacific Injectable Targeted Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Injectable Targeted Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Injectable Targeted Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Injectable Targeted Therapy Market Size by Region
8.4.1 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Injectable Targeted Therapy Market Size (2016-2027)
9.2 Latin America Injectable Targeted Therapy Market Size by Type
9.2.1 Latin America Injectable Targeted Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Injectable Targeted Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Injectable Targeted Therapy Market Size by Type (2016-2027)
9.3 Latin America Injectable Targeted Therapy Market Size by Application
9.3.1 Latin America Injectable Targeted Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Injectable Targeted Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Injectable Targeted Therapy Market Size by Application (2016-2027)
9.4 Latin America Injectable Targeted Therapy Market Size by Country
9.4.1 Latin America Injectable Targeted Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Injectable Targeted Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Injectable Targeted Therapy Market Size (2016-2027)
10.2 Middle East & Africa Injectable Targeted Therapy Market Size by Type
10.2.1 Middle East & Africa Injectable Targeted Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Injectable Targeted Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Injectable Targeted Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Injectable Targeted Therapy Market Size by Application
10.3.1 Middle East & Africa Injectable Targeted Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Injectable Targeted Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Injectable Targeted Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Injectable Targeted Therapy Market Size by Country
10.4.1 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Injectable Targeted Therapy Introduction
11.1.4 Novartis Revenue in Injectable Targeted Therapy Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Injectable Targeted Therapy Introduction
11.2.4 Sanofi Revenue in Injectable Targeted Therapy Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Injectable Targeted Therapy Introduction
11.3.4 GSK Revenue in Injectable Targeted Therapy Business (2016-2021)
11.3.5 GSK Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Injectable Targeted Therapy Introduction
11.4.4 Bayer Revenue in Injectable Targeted Therapy Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Injectable Targeted Therapy Introduction
11.5.4 Amgen Revenue in Injectable Targeted Therapy Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Injectable Targeted Therapy Introduction
11.6.4 Merck Revenue in Injectable Targeted Therapy Business (2016-2021)
11.6.5 Merck Recent Development
11.7 AbbiVie
11.7.1 AbbiVie Company Details
11.7.2 AbbiVie Business Overview
11.7.3 AbbiVie Injectable Targeted Therapy Introduction
11.7.4 AbbiVie Revenue in Injectable Targeted Therapy Business (2016-2021)
11.7.5 AbbiVie Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Injectable Targeted Therapy Introduction
11.8.4 AstraZeneca Revenue in Injectable Targeted Therapy Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva Injectable Targeted Therapy Introduction
11.9.4 Teva Revenue in Injectable Targeted Therapy Business (2016-2021)
11.9.5 Teva Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Injectable Targeted Therapy Introduction
11.10.4 Roche Revenue in Injectable Targeted Therapy Business (2016-2021)
11.10.5 Roche Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Injectable Targeted Therapy Introduction
11.11.4 Pfizer Revenue in Injectable Targeted Therapy Business (2016-2021)
11.11.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 注射式標的治療の世界市場規模・現状・予測2021年-2027年(Global Injectable Targeted Therapy Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。